Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Income from Continuing Operations (2016 - 2025)

Altimmune (ALT) has disclosed Income from Continuing Operations for 16 consecutive years, with 57890000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 11.24% to 57890000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2845000.0 through Dec 2025, up 57.27% year-over-year, with the annual reading at 2845000.0 for FY2025, 57.27% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 57890000.0 at Altimmune, up from 19014000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 65221000.0 in Q4 2024, with the low at 33510000.0 in Q3 2021.
  • Average Income from Continuing Operations over 5 years is 6789490.75, with a median of 20112500.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations tumbled 282.54% in 2021, then surged 256.85% in 2023.
  • Over 5 years, Income from Continuing Operations stood at 54694000.0 in 2021, then tumbled by 139.7% to 21713000.0 in 2022, then soared by 256.85% to 34056000.0 in 2023, then surged by 91.51% to 65221000.0 in 2024, then decreased by 11.24% to 57890000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 57890000.0, 19014000.0, and 22146000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.